Most Active Biotech Investors in Cambridge, UK 2026
9 firms writing Biotech checks in Cambridge, UK, led by Business Growth Fund, LocalGlobe, Montage Ventures — ranked by verified deal count with the companies.
Biotech in Cambridge, UK accounts for 43 tracked companies with verified cap-table data, 43 of which disclose round sizes totalling $7.9B. The median disclosed raise is $115M, and the largest is Beam Therapeutics at $1B, ahead of Hemab ($537M) and Parabilis Medicines ($500M).
The names that recur most often on these biotech cap tables are Atlas Venture (9 companies), RA Capital Management (8 companies), Flagship Pioneering (5 companies), Khosla Ventures (4 companies), Catalio Capital Management (4 companies), Third Rock Ventures (4 companies). By latest disclosed round, the market skews Series A (20), Series B (7), Series C (5), Seed (4).
Companies tracked: 43
Disclosed funding total: $7.9B across 43 companies
Median disclosed raise: $115M
Largest raise: Beam Therapeutics — $1B
Stage mix: Series A 20 · Series B 7 · Series C 5 · Seed 4
